SCHEMBL11137643

SCHEMBL11137643

O=C(O)CCCCCCCn1c(=O)[nH]c2ccccc21.[Na]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.61
KDM4E B2RXH2 2/20 0.61
HSD17B10 Q99714 1/20 0.61
ALDH1A1 P00352 2/20 0.59
HPGD P15428 2/20 0.59
LMNA P02545 2/20 0.59
MAPT P10636 1/20 0.59
TSHR P16473 1/20 0.59
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
POLB P06746 1/20 0.59
HTR7 P34969 4/20 0.58
FABP4 P15090 1/20 0.56
FABP5 Q01469 1/20 0.56
P2RX7 Q99572 4/20 0.55
RAB9A P51151 1/20 0.52
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11138401 0.99 MAPK1 (0.63) MAPK1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL30530511 0.93 MAPK1 (0.70) MAPK1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL97551 0.93 MAPK1 (0.70) MAPK1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL4313671 0.87 HPGD (0.68) MAPK1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL27780501 0.85 MAPK1 (0.61) MAPK1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL11137640 0.85 LMNA (0.58) MAPK1ALDH1A1HPGDLMNAMAPT
SCHEMBL11132570 0.83 LMNA (0.56) MAPK1ALDH1A1HPGDLMNAMAPT
SCHEMBL30947438 0.82 LMNA (0.78) MAPK1ALDH1A1HPGDLMNAMAPT
SCHEMBL10540636 0.81 LMNA (0.57) MAPK1ALDH1A1HPGDLMNAMAPT
SCHEMBL97994 0.80 LMNA (0.62) MAPK1KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4377695-A ANTIINFLAMMATORY, ANALGESIC, ANTICOAGULANT AGENTS A. NATTERMANN & CIE GMBH (DE) 1983-03-22 US disclosed
EP-0051827-A1 Omega-(2-oxo-benzimidazolinyl)-alkanoic acid derivatives, process for producing the same and pharmaceutical compounds containing the same A. Nattermann & Cie. GmbH (DE) 1982-05-19 EP disclosed